Back to top

BioAge Labs reports Q2 EPS (58c), consensus (62c)

Reports Q2 revenue $2.45M, consensus $1.5M. “NLRP3 sits at the apex of the inflammatory cascade that drives a range of diseases,” said Kristen Fort...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioAge Labs, Inc. (BIOA)